SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    Archive:
    News and Articles on National Institute of Allergy and Infectious Diseases

    Latest News: National Institute of Allergy and Infectious Diseases

    Report: Swine flu to affect 2 million  Aug 25, 2009
    "We think its very likely cases will increase," said David Marens, a flu expert at the National Institute of Allergy and Infectious Diseases. Unlike previous analyses, the White House science advisors drew from experience with past pandemics to attempt to forecast the impact of the 2009-2010 H1N1 flu. (Florida Today)

    Swine Flu Vaccine Seems Safe in Early Trials  Aug 25, 2009
    "A number of clinical trials were designed and have begun to ask fundamental questions that would inform how we would use the virus, the proper dose, some early safety data as well as the use of the vaccine in certain populations," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said during an afternoon press conference ... SOURCES: Aug. 21, 2009, press conference with Anthony Fauci, M.D., director, National Institute of Allergy and Infectious... (MEDLINEplus)

    Friendly Gut Bacteria Lend A Hand To Fight Infection, Study Suggests  Aug 24, 2009
    The work was supported by the National Institute of Allergy and Infectious Diseases and the Howard Hughes Medical Institute. Adapted from materials provided by. (Science Daily)

    • Researchers expose kids to risky foods in order to cure them  Aug 23, 2009
    "There's been a substantial uptick in the amount of research," said Marshall Plaut of the National Institute of Allergy and Infectious Diseases, which has more than doubled the funding for food-allergy research since 2007. "I think it's time to be cautiously optimistic.". (Burley South Idaho Press, ID)

    Shingles Complications and Treatmen...  Aug 23, 2009
    According to a 2000 article in Opthamology Times by Lynda Charters and Alan Palestine entitled Famcyclovir an option for ophthalmic zoster," Famcyclovir may reduce symptoms of herpes zoster opthalmicus, particularly if started early in the progression of the infection. This article indicates that famcyclovir is more effective than acyclovir in treating herpes zoster opthalmicus. Bacterial Infection Resulting From a Shingles Infection According to the CDC, a superinfection of bacteria may occur... (Suite101.com)

    No red flags in swine flushot tests  Aug 22, 2009
    "There are no red flags regarding safety," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health. advertisement. (MSNBC -- Health)

    Chile: Tests show swine flu has jumped to birds  Aug 22, 2009
    But they haven't received any reports of a dangerous mutation yet, and the fact that the virus can spread to turkeys was not all that surprising, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaking at a Friday news conference in Atlanta. Click for related content. (MSNBC -- Health)

    Swine Flu May Not Close College Classrooms  Aug 22, 2009
    Vaccine trials have already begun in adults, and on Tuesday officials at the U.S. National Institute of Allergy and Infectious Diseases announced that two clinical trials testing the effectiveness of candidate vaccines for children are set to "begin shortly.". "Students need to be encouraged, not only to take care of themselves and isolate themselves when they are sick, but, hopefully take advantage of the vaccine when it becomes available," U.S. Secretary of Health and Human Services Kathleen... (MEDLINEplus)

    So far, no "red flags" seen in H1N1 vaccine  Aug 22, 2009
    National Institute of Allergy and Infectious Diseases. Add Selected Alerts. (Yahoo News -- Pharmaceutical Industry News)

    Businesses Need Swine Flu Action Plan, U.S. Says  Aug 21, 2009
    Vaccine trials have already begun in adults, and on Tuesday officials at the U.S. National Institute of Allergy and Infectious Diseases announced that two clinical trials testing the effectiveness of candidate vaccines for children are set to "begin shortly.". SOURCES: Aug. 19, 2009, news briefing with Gary Locke, secretary, U.S. Department of Commerce; Aug. 19, 2009, Guidance for Businesses and Employers to Plan and Respond to the 2009-2010 Influenza Season, U.S. Centers for Disease Control and... (MEDLINEplus)

    Sars patients can provide therapy  Aug 21, 2009
    A team from the US National Institute of Allergy and Infectious Diseases then tested the most effective of these antibodies in mice and found they prevented the virus from multiplying in the respiratory system. Dr Lanzavecchia said: "At present there is no immunological treatment for Sars, and a vaccine may take several years to produce. "Our approach produces protective antibodies that would provide immediate protection against the Sars virus. (Yahoo News -- SARS)

    Swine flu shots seem safe enough to test kids  Aug 20, 2009
    The National Institute of Allergy and Infectious Diseases said it would soon start two trials of Sanofi-Aventis' vaccine in children aged 6 months to 17 years old. "The safety monitoring committee reviewed data from more than 500 healthy adult and elderly volunteers enrolled in three ... trials of candidate H1N1 vaccines that began August 7, 2009," the NIAID, part of the National Institutes of Health, said in a statement. (MSNBC -- Health)

    UTMB to join BCM in H1N1 vaccine trials  Aug 15, 2009
    The medical center has been selected by the National Institute of Allergy and Infectious Diseases to conduct pediatric vaccine trials. Because children have had so many fewer seasons of exposure to influenza, their immune systems are considered na ve and at much higher risk for serious illness and death than adults, Dr. Christine Turley, vice chairwoman for pediatric clinical services at UTMB, said. (Houston Business Journal, TX)

    Still Searching For Predictors Of Asthma Attacks  Aug 14, 2009
    The study was conducted by the Inner City Asthma Consortium (ICAC), a nationwide network of clinical researchers supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. ICAC member Rebecca Gruchalla, M.D., Ph. (Science Daily)

    Swine Flu May Not Be Any Deadlier This Fall  Aug 13, 2009
    David Morens and Jeffery Taubenberger, infectious disease experts at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. In an article published in the Aug. 12 issue of the Journal of the American Medical Association, the experts take on a much-publicized theory that's helped stoke fears about a resurgence of swine flu in the Northern Hemisphere this fall. (MEDLINEplus)

    Past Flu Pandemics Studied For Clues To Future Course Of 2009 H1N1 Virus  Aug 13, 2009
    But two scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, say the existing data are insufficient to conclude decisively that the 1918-19 pandemic was presaged by a mild, so-called spring wave, or that the responsible virus had increased in lethality between the beginning and end of 1918. See also. (Science Daily)

    Found: A Gene That May Play A Role In Type 1 Diabetes  Aug 12, 2009
    Dr. Fathman is a grantee of the National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases, both components of the National Institutes of Health. Additional funding for the study was provided by the Special Statutory Funding Program for Type 1 Diabetes Research, a special appropriation for research on the prevention and cure for type 1 diabetes. (Science Daily)

    What's an Adjuvant and Will It Be in Your Swine Flu Vaccine?  Aug 12, 2009
    "It wasn't felt to be necessary, because the flu vaccines that have been used for decades in this country were rather broadly protective," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "We felt that the immune response of the vaccine was pretty good to begin with.". (ABC News)

    Volunteers roll up sleeves for first swine flu shots  Aug 8, 2009
    Vaccines were shipped to eight Vaccine Treatment and Evaluation Units across the nation Thursday night, said Linda Perrett, a spokeswoman for the National Institute of Allergy and Infectious Diseases, which is coordinating the trials. Rolling out the vaccineStarting Monday, hundreds of volunteers nationwide will join the fast-track tests that must be completed before nationwide vaccine distribution can begin, probably in mid-October. (MSNBC -- Race)

    Michael Gerson: D.C. needle-exchange program does far more good than harm  Aug 7, 2009
    Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, has comprehensively reviewed the scientific studies on needle exchange. "It does not," he says, "result in an increase in drug abuse, and it does decrease the incidence of HIV. The idea that kids are going to walk out of school and start using drugs because clean needles are available is ridiculous.". (Sacramento Bee -- Opinion)

    Researchers ID new HIV strain from gorillas  Aug 5, 2009
    Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, calls the latest HIV variant "an oddity" but said it's not surprising that it cropped up, because the virus has been circulating in non-human primates for centuries. The three previous HIV variants are labeled M, N and O. The new one has been classified P. The N and O variants, Fauci said, are extremely rare. (CNN -- Health)

    People Who Eat Deer And Elk With Chronic Wasting Disease May Avoid Infection Because Of Species Barrier, Study in Monkeys Suggests  Aug 4, 2009
    RML is part of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The RML group is leading the study with collaborators from the Colorado Division of Wildlife; State University of New York Downstate Medical Center; New York State Institute for Basic Research in Developmental Disabilities; American Red Cross; and the University of Wyoming. (Science Daily)

    Scientists learn why even treated genital herpes sores boost the risk of HIV infection  Aug 3, 2009
    D., of the Fred Hutchinson Cancer Research Center and Anna Wald, M.D., M.P.H., of the University of Washington, both in Seattle, the study was funded mainly by the National Institute of Allergy and Infectious Diseases (NIAID) with support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, both part of the National Institutes of Health. "The findings of this study mark an important step toward understanding why HSV-2 infection increases the risk of acquiring... (EurekAlert!)

    Genes key to staph disease severity, drug resistance found hitchhiking together  Aug 1, 2009
    Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, led the study. They collaborated with researchers at the University of Tubingen in Germany and the University of Medicine and Dentistry of New Jersey. (EurekAlert!)

    Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia  Aug 1, 2009
    The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID). Conference Call to Discuss the Restanza CAP NDA. (PR Newswire)

    UNC gets $3.5M grant for HIV study  Jul 31, 2009
    The grant, from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will cover the costs of a four-year study to identify and inform people with acute HIV infection and create and evaluate potential intervientions. Acute HIV infection is the time between when a person is infected and when HIV is detected. (Triangle Business Journal)

    PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach  Jul 29, 2009
    This prime vaccine candidate is currently being tested in a Phase 1 study in partnership with the National Institute of Allergy and Infectious Diseases. This new collaboration will make it possible to clinically develop the Ad26 boost component of the vaccine and allow Crucell to further strengthen and expedite its malaria development program. (EurekAlert! -- Business News)

    Swine Flu Shot May Require Emergency Use of Ingredients by Glaxo, Novartis  Jul 29, 2009
    Novartis, based in Basel, Switzerland, is responsible for 45 percent of the supply, while Sanofi will provide 26 percent and CSL will make 19 percent, said , director of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, in an interview last week. The remaining doses will be made by Glaxo and London-based drugmaker. (Bloomberg -- US)

    Another view: Vaccine in works for the swine flu  Jul 28, 2009
    At the direction of the National Institute of Allergy and Infectious Diseases, eight university research hospitals and medical groups across the country including the University of Maryland School of Medicine's Center for Vaccine Development will soon enroll 1,000 adults, seniors and children to test a potential vaccine. The trial will start with 200 healthy adults and 200 seniors. (Montana Standard, MT)

    Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates Set  Jul 26, 2009
    The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. See also. (Science Daily)

    Africa: Trial of Continent's First HIV Vaccines Underway  Jul 24, 2009
    The SAAVI 102/HVTN 073 trial is a collaboration between the South African branch of the international HIV Vaccine Trials Network and the US National Institute of Allergy and Infectious Diseases (NIAID). The vaccines, SAAVI MVA-C and SAAVI DNA-C2, developed at the University of Cape Town, are based on HIV sub-type C - the dominant strain in South Africa - and have shown promising results in animal testing. (allAfrica.com)

    * US authorities to launch trials of swine flu vaccines  Jul 24, 2009
    We have undertaken a collaborative and efficient process of vaccine development that is proceeding in stepwise fashion, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. The US is now the country worst hit by the outbreak of the A(H1N1) virus, with more than 40,600 cases reported across all 50 states and 263 deaths. (Taipei Times, Taiwan -- World Business)

    Chimps Do Get "AIDS," Study Finds  Jul 24, 2009
    Past evidence had supported the view that SIV doesn't lead to a lethal condition in apes and monkeys, explained AIDS researcher Daniel Douek of the U.S. National Institute of Allergy and Infectious Diseases. But the study authors "have now conclusively challenged this notion," said Douek, who was not involved in the new research. (National Geographic)

    U.S. Swine Flu Vaccine Trials Set to Begin  Jul 24, 2009
    Two possible vaccines will be tested at eight institutions around the country under the auspices of the National Institute of Allergy and Infectious Diseases (NIAID) ... SOURCES: John J. Treanor M.D., professor, medicine, microbiology and immunology, University of Rochester Medical Center, Rochester, N.Y.; July 22, 2009, news releases, U.S. National Institute of Allergy and Infectious Diseases, and University of Maryland School of Medicine; July 17, 2009, teleconference with Anne Schuchat, M.D.,... (MEDLINEplus)

    Bcl6 gene sculpts helper T cell to boost antibody production  Jul 24, 2009
    The work is supported by research grants from the National Institute of Allergy and Infectious Diseases, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, M. D. Anderson Cancer Center's Center for Targeted Therapy and the Leukemia and Lymphoma Society. Martinez is a Schissler Foundation Fellow in cancer research and a student in The University of Texas Graduate School of Biomedical Sciences, a joint program of M. D. Anderson and the UT Health Science Center at Houston. (EurekAlert!)

    Emory University to test flu vaccines  Jul 23, 2009
    The clinical trials will be conducted through the Vaccine and Treatment Evaluation Units of the National Institute of Allergy and Infectious Diseases of the (NIH). In August, Emory will recruit healthy adults, seniors and children for the clinical trials, which have been hurried due to the possible fall resurgence of H1N1 flu infections that may also coincide with the circulation of new seasonal flu strains in the Northern Hemisphere. (Atlanta Business Chronicle, GA)

    In trials for H1N1 vaccine, dosage is key  Jul 23, 2009
    Source: The National Institute of Allergy and Infectious Diseases. SWINE FLU: H1N1 VIRUS. (USA Today)

    State opts not to give flu shots at schools  Jul 23, 2009
    Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, the federal agency directing the clinical trials, says the timetable is "very tight.". Fauci said the most likely scenario involves a gradual rollout of H1N1 vaccine, meaning that some people will have to get a seasonal flu shot and then return weeks, or even months, later for the second booster. (AZCentral -- News)

    Zambia: HIV Prevention Trial to Start  Jul 23, 2009
    The trial funded by the National Institute of Allergy and Infectious Diseases (NIAID), was conducted in six African countries, including Zambia and the United States. The first human clinical study to suggest that a microbicide, a gel, intended to prevent the sexual transmission of HIV and other sexually transmitted infections when applied topically inside the vagina or rectum-could prevent male-to-female sexual transmission of HIV infection. (allAfrica.com)

    Common Cold Virus Efficiently Delivers Corrected Gene To Cystic Fibrosis Cells  Jul 23, 2009
    D., all of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The research was funded by the National Institutes of Health and the Cystic Fibrosis Foundation. (Science Daily)

    Science uncovers genetic secrets of killer parasites  Jul 17, 2009
    Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said: "Chronic infection with Schistosoma parasites makes life miserable for millions of people in tropical countries around the globe and can lead to death.". "New drugs and other interventions are badly needed to reduce the impact of a disease that lowers quality of life and slows economic development", he added. (Guardian News, Nigeria)

    Genomes Of Parasitic Flatworms Decoded  Jul 16, 2009
    The research was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), and is published in the current issue of Nature. The genomic information obtained through these sequencing projects suggests ways to design drugs or other compounds targeted specifically at proteins or other gene products required by the parasite to find or survive in its human or snail host. (Science Daily)

    Killer parasites' genes decoded  Jul 16, 2009
    Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said: "Chronic infection with Schistosoma parasites makes life miserable for millions of people in tropical countries around the globe, and can lead to death. "New drugs and other interventions are badly needed to reduce the impact of a disease that lowers quality of life and slows economic development. " Since the 1980s, a cheap drug, praziquantel has been widely distributed to areas where the disease is... (BBC News -- Health)

    Researchers map how staph infections alter immune system  Jul 14, 2009
    Researchers from the Baylor Institute for Immunology Research, Baylor National Institute of Allergy and Infectious Diseases Cooperative Center for Translational Research on Human Immunology and Biodefense, the Baylor Institute for Immunology Research and the Baylor Research Institute also contributed. The work was supported by the National Institutes of Health, the Center for Lupus Research and the Baylor Health Care System Foundation. (EurekAlert!)

    Australia braces for mass swine flu vaccination  Jul 14, 2009
    Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the United States, said last week that clinical trials on a first candidate vaccine were expected to begin next month. The race for a vaccine is accelerating as governments worldwide brace for the northern hemisphere's return of the regular influenza strain, which kills many thousands every year. (Sydney Morning Herald -- World)

    Infectious Disease Researchers Advancing Vaccine Against Valley Fever  Jul 14, 2009
    This most recent study has been funded by the National Institute of Allergy and Infectious Diseases, the California HealthCare Foundation and the Margaret Batts Tobin Foundation. "Respiratory infections caused by Coccidioides tend to escape the radar of most large pharmaceutical companies, because only about 100,000 cases are reported each year," said Garry Cole, professor of biology at UTSA and the study's principal investigator. (Science Daily)

    New Pill May Prevent Injury After Radiation Exposure  Jul 14, 2009
    Funding for this study was provided by the U.S. Centers for Medical Countermeasures Against Radiation (CMCR) program, administered by National Institute of Allergy and Infectious Diseases. The study was initiated with CMCR "Pilot Grant" funding awarded to Dr. Rosalind Rosenthal, first author of the paper and currently a research associate at BUSM.. (Science Daily)

    New oral agents may prevent injury after radiation exposure  Jul 11, 2009
    Funding for this study was provided by the U.S. Centers for Medical Countermeasures Against Radiation (CMCR) program, administered by National Institute of Allergy and Infectious Diseases. The study was initiated with CMCR "Pilot Grant" funding awarded to Dr. Rosalind Rosenthal, first author of the paper and currently a research associate at BUSM. Doctrow's laboratory at BUSM is a member of a five-institution CMCR program, based at the Medical College of Wisconsin in Milwaukee. (EurekAlert!)

    Drug gives anthrax protection in animal studies  Jul 9, 2009
    In an editorial accompanying the study, Dr. Gary Nabel, director of vaccine research at the National Institute of Allergy and Infectious Diseases, said results suggest ABthrax could provide "an important addition to the existing arsenal" that doctors have against anthrax. 2009 The Associated Press. (MSNBC -- Health)

    Protecting against Future Shock — Inhalational Anthrax  Jul 9, 2009
    From the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.. This article has been cited by other articles. (New England Journal of Medicine)

    Flu Dynasty: Influenza Virus In 1918 And Today  Jun 30, 2009
    ScienceDaily (June 30, 2009) The influenza virus that wreaked worldwide havoc in 1918-1919 founded a viral dynasty that persists to this day, according to scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. See also. (Science Daily)

    STAT3 Protein Found To Play A Key Role In Cancer  Jun 28, 2009
    ScienceDaily (June 27, 2009) A protein called STAT3 has been found to play a fundamental role in converting normal cells to cancerous cells, according to a new study led by David E. Levy, Ph. D., professor of pathology and microbiology at NYU Langone Medical Center. (Science Daily)

    Dr. Jean Dausset, Nobel laureate, 92  Jun 27, 2009
    Dr. Dausset s findings transformed understanding of the immune system, Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a telephone interview Monday. Dr. Dausset s main achievement was demonstrating that molecules on the surface of cells, now called HLA antigens, determine an individual s immune response. (Boston Globe)

    'FDA has a lot on its plate' as new chief takes over  Jun 17, 2009
    Posts held: Assistant director, National Institute of Allergy and Infectious Diseases, 1989-1990; New York City health commissioner, 1991-1997; vice president for biological programs at the Nuclear Threat Initiative, 2001-2009 ... She says much of her career, including stints as New York City health commissioner and assistant director of the National Institute of Allergy and Infectious Diseases, has focused on vaccines and diagnostics. (USA Today)

    New Strategy Proposed For Designing Antibody-based HIV Vaccine  Jun 17, 2009
    But several recent studies suggest promising new research directions for the development of an antibody-based HIV vaccine, according to John R. Mascola, M.D., deputy director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, and colleagues. These studies demonstrate that, contrary to widespread belief, it is not uncommon for people infected with HIV to naturally make antibodies that can neutralize a variety of HIV... (Science Daily)

    Killer Virus ID'd In Africa  May 30, 2009
    "It's not a kind of virus like the flu that can spread widely," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which helped fund the research. The name given to the virus -; "Lujo" - stems from Lusaka and Johannesburg, the cities where it was first identified. (CBS News)

    Refusing Immunizations Puts Children At Increased Risk Of Pertussis Infection, Study Finds  May 29, 2009
    Funded by the National Institute of Allergy and Infectious Diseases, this is the first study to use electronic health records to look for immunization refusal and possible pertussis infections, making it the most definitive on the risk of vaccine refusal to date. While most families vaccinate their children, leading to dramatic reductions in several serious childhood illnesses, the number of parents refusing immunizations appears to be increasing in the United States, researchers say. (Science Daily)

    Study: Unvaccinated at risk  May 27, 2009
    A grant from the National Institute of Allergy and Infectious Diseases paid for the work. Oregon had 124 reported cases of pertussis in 2007, the most recent year of complete figures. (OregonLive, OR -- News)

    Regular Flu Vaccine Little Help Against New Strain  May 23, 2009
    The researchers at the CDC, Food and Drug Administration, National Institute of Allergy and Infectious Diseases, along with, universities and vaccine makers, looked at blood samples given after people were vaccinated for seasonal flu. Seasonal flu vaccines carry an H1N1 component, an H3N2 strain and an influenza B strain. (MEDLINEplus)

    Sars patients can provide therapy  May 22, 2009
    A team from the US National Institute of Allergy and Infectious Diseases then tested the most effective of these antibodies in mice and found they prevented the virus from multiplying in the respiratory system. Dr Lanzavecchia said: "At present there is no immunological treatment for Sars, and a vaccine may take several years to produce. "Our approach produces protective antibodies that would provide immediate protection against the Sars virus. (Yahoo News -- SARS)

    Older Adults May Have Some Immunity to Swine Flu  May 22, 2009
    In 1977, the H1N1 "Russian flu" virus emerged, but people exposed to H1N1 before 1957 were largely immune to this strain, according to the U.S. National Institute of Allergy and Infectious Diseases. Jernigan said studies have found evidence of H1N1 antibody activity in blood from older people. (MEDLINEplus)

    Computer Simulation Captures Immune Response To Flu  May 21, 2009
    D., co-director of the CBIM. The work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the U.S. Department of Energy. "High-speed, accurate computer simulation tools are urgently needed to dissect the relative importance of each attribute of viral strains in their ability to cause disease, and the contribution of each part of the immune system in a successful counterattack," said Zand. (Science Daily)

    Engineered antibodies to fight AIDS  May 19, 2009
    "As a concept, I think this is very promising," Peggy Johnston, head of the HIV Vaccine Research Branch at the National Institute of Allergy and Infectious Diseases, which helped pay for the study, said in a telephone interview. She said the monkeys had an immune response to the AAV virus and the approach would have to be carefully tested to ensure it was safe. (India Times, India)

    New AIDS approach looks to outflank virus  May 19, 2009
    The research was supported by the National Institute of Allergy and Infectious Diseases. This article appeared on page A - 9 of the San Francisco Chronicle. (San Francisco Chronicle)

    Researchers aim to outflank AIDS virus  May 18, 2009
    The research was supported by the National Institute of Allergy and Infectious Diseases. (). (Globe and Mail)

    Rational Design Of Vaccines: A Long But Essential Journey  May 17, 2009
    ScienceDaily (May 16, 2009) The holy grail of the defence mechanism against infectious diseases and tumours has not yet been discovered. In the search for a master switch in the immune apparatus of humans and animals, many strategies still need to be explored before the enormous potency of this complex system can be activated and controlled in the right manner. (Science Daily)

    Rocky Mountain Labs involved in swine flu study (28)  May 17, 2009
    The National Institute of Allergy and Infectious Diseases, in response to an inquiry on swine flu from the Ravalli Republic, confirmed that RML scientists have begun a study to develop an animal model of the virus' infection in nonhuman primates. Rocky Mountain Labs' new Laboratory of Virology is now operating in the recently completed Integrated Research Facility; there, scientists will study how the swine flu infection spreads in animals, where the virus replicates, which organs it affects,... (Missoulian, MT)

    BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units  May 16, 2009
    This study was funded by the United States Agency for International Development, the Health Resources and Services Administration and the National Institute of Allergy and Infectious Diseases. These organizations had no role in the design and conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation, review and approval of the manuscript. (EurekAlert!)

    Mathematical Model Developed To Predict Immune Response To Influenza  May 15, 2009
    The project was conducted by investigators funded through the Modeling Immunity for Biodefense program, a program established in 2005 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to improve preparedness for emerging and re-emerging pathogens. When an individual is infected by a virus, a network of immune cells becomes immediately engaged, taking up viral particles and presenting pieces of the virus antigens to specialized white... (Science Daily)

    RML adds swine flu study to its repertoire  May 14, 2009
    The National Institute of Allergy and Infectious Diseases (NIAID), in response to an inquiry on swine flu from the Ravalli Republic, confirmed that RML scientists have begun a study to develop an animal model of the virus infection in nonhuman primates. The revelation comes on the heels of Monday s news that the federal Centers for Disease Control and Prevention has confirmed Montana s first case of swine flu, an infection involving an adult male in Yellowstone County. (Minnesota Farm Guide, MN)

    SRI International to screen drugs that fight 2009 H1N1 influenza A  May 14, 2009
    May 13, 2009 SRI International, an independent, nonprofit research and development organization, announced today that that it will screen a library of well-characterized drugs against the 2009 H1N1 influenza A virus, previously known as "swine flu." The work will be performed under a resource contract from the Division of Microbiology and Infectious Diseases (DMID) in the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. There is currently... (EurekAlert! -- Business News)

    InDevR's FluChip detects and distinguishes swine-origin H1N1 from human influenza viruses  May 6, 2009
    "The FluChip assay detected all of the 6 swine-origin H1N1 viruses tested, and the resulting pattern, or signature, on the microarray was dramatically different than the signature for seasonal A/H1N1 and A/H3N2 viruses. Interestingly, the signature of the swine H1N1 virus indicated an avian component within the M-gene, which is consistent with its reported Eurasian lineage, said Dr. Erica Dawson, the Lead Scientist on the project at InDevR and co-inventor of the FluChip technology.... (EurekAlert! -- Business News)

    Natural Remedies for ADHD  May 5, 2009
    According to the National Institute of Allergy and Infectious Diseases, foods that are most likely to trigger an allergic reaction in children include peanuts, eggs, and milk. Ease Symptoms with Meditation. (Suite101.com)

    Deadlier Flu Strain Would Overwhelm Systems...  May 1, 2009
    director of the National Institute of Allergy and Infectious Diseases, on vaccine efforts. More. (The Drudge Report)

    New Understanding Of Dengue Virus Points Way To Possible Therapies For Dengue Fever  May 1, 2009
    The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, funded the study. Duke co-authors who contributed to the study include October Sessions, the lead author of the study; and Nicholas Barrows, Timothy Robinson and James Pearson. (Science Daily)

    First Swine Flu Death Reported in U.S.  May 1, 2009
    The earliest a vaccine could be ready is this fall, said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. During a press briefing Tuesday, Besser had said that the cases of infection found in the United States so far continued to be mild, but more severe cases were expected, and "as we move forward, I fully expect we will see deaths.". (MEDLINEplus)

    Virus samples sent as drugmakers await vaccine go-ahead  Apr 30, 2009
    Reference strains for the virus were distributed and a pre- planned development process is under way, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, at a news conference today in Washington. The National Institutes of Health, the parent agency, plans to perform clinical tests to determine the vaccine dose and it may be tested in people within "a couple of months" Fauci said. (Honolulu Advertiser)

    Influenza evolving  Apr 30, 2009
    "So it has to keep mutating to escape being destroyed," explains David Morens from the US National Institute of Allergy and Infectious Diseases ... David Morens National Institute of Allergy and Infectious Diseases. (BBC News -- Health)

    Phase 1 trial of whole-parasite malaria vaccine to begin  Apr 28, 2009
    Sanaria has overcome the initial technological and regulatory barriers with support from many partners and colleagues, including those at the National Institute of Allergy and Infectious Diseases, the US Military Malaria Vaccine Program, the US Army Military Infectious Diseases Research Program, the Institute for One World Health, the PATH Malaria Vaccine Initiative, and the University of Maryland School of Medicine Center for Vaccine Development. Sanarias facilities are in Rockville, MD. For... (EurekAlert! -- Business News)

    Uncovering Secrets Of Salmonella's Stealth Attack  Apr 18, 2009
    17, 2009) A single crafty protein allows the deadly bacterium Salmonella enterica to both invade cells lining the intestine and hijack cellular functions to avoid destruction, Yale researchers report in the April 17 issue of the journal Cell. This evolutionary slight-of-hand sheds new insights into the lethal tricks of Salmonella, which kills more than 2 million people a year. (Science Daily)

    OHSU scientists partner with others to form center aimed at combating infectious diseases  Apr 16, 2009
    7 million cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. Jay Nelson, Ph. (EurekAlert!)

    Gene Targeting Opens Door For Vaccines, Drugs  Apr 14, 2009
    Gene Targeting Discovery Opens Door For Vaccines And Drugs. Gene Targeting Discovery Opens Door For Vaccines And Drugs. (Science Daily)

    Dartmouth Medical School gene targeting discovery opens door for vaccines and drugs  Apr 14, 2009
    " ###Coauthors of the study (in Vol. 8, No. 4: 520-529) are Jessica Ristuccia, a former research assistant now at Tufts School of Dental Medicine, and Jason Gigley, a former student now at George Washington University. The work was funded by grants from the NIH National Institute of Allergy and Infectious Diseases.. (EurekAlert!)

    Discovery Of Tuberculosis Bacterium Enzyme Paves Way For New TB Drugs  Apr 2, 2009
    "NadE [NAD+ synthetase] represents one of a small handful of TB drug targets that has iron-clad validation, the lack of a crystal structure was the only serious impediment to drug development and this study represents a hugely important step forward" said Clifton E. Barry, Chief of the Tuberculosis Research Section of the Intramural Research Division of the National Institute of Allergy and Infectious Diseases. "Inhibiting NadE even kills non-replicating cells, so this discovery may well benefit... (Science Daily)

    New Role For Lung Epithelial Cells In Sensing Allergens In Air  Apr 2, 2009
    1, 2009) Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and at Ghent University in Ghent, Belgium, have identified a new role for certain lung cells in the immune response to airborne allergens. See also. (Science Daily)

    Latest News: National Institute of Allergy and Infectious Diseases

    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2009